Relationship Between Adiponectin Levels and Cognitive Function in Elderly Patients with Obesity in RSUD Dr. Mohamad Soewandhie Surabaya

Salwa Salsabila; Rahajoe Imam Santoso; Hernycane Sosilya

doi:10.55606/ijhs.v6i1.6897

Authors

Salwa Salsabila Universitas Ciputra
Rahajoe Imam Santoso Universitas Ciputra
Hernycane Sosilya Universitas Ciputra

DOI:

https://doi.org/10.55606/ijhs.v6i1.6897

Keywords:

Adiponectin, Cognitive Function, Elderly, MoCa-Ina, Obesity

Abstract

Obesity in the elderly is an increasingly prevalent condition and is associated with a higher risk of metabolic disorders and cognitive decline. Adiponectin, an adipokine with anti-inflammatory and neuroprotective properties, is thought to play a role in maintaining cognitive function through the regulation of metabolism and inflammatory responses. However, scientific evidence regarding the association between adiponectin and cognitive function among obese elderly individuals in Indonesia remains limited. This study aimed to describe adiponectin levels, cognitive function, and the relationship between the two among obese elderly patients at RSUD dr. Mohamad Soewandhie Surabaya. This study employed an analytic observational design with a cross-sectional approach and involved obese elderly respondents selected using a total sampling technique. Adiponectin levels were measured using the Enzyme-Linked Immunosorbent Assay (ELISA) method, while cognitive function was assessed using the Indonesian version of the Montreal Cognitive Assessment (MoCA-Ina). Data analysis was performed using the Shapiro–Wilk normality test and Spearman's rho correlation test. The results showed a statistically significant relationship between adiponectin levels and cognitive function among obese elderly individuals (p = 0.731; r < 0.01). In conclusion, this study found that adiponectin levels were associated with cognitive function in the obese elderly population examined.

Downloads

Download data is not yet available.

References

Begum, M., et al. (2023). Adiponectin: A promising target for the treatment of diabetes and its complications. Life, 13(11). https://doi.org/10.3390/life13112213

Cezaretto, A., et al. (2018). Association of adiponectin with cognitive function precedes overt diabetes in the Brazilian Longitudinal Study of Adult Health (ELSA). Diabetology & Metabolic Syndrome, 10(1). https://doi.org/10.1186/s13098-018-0354-1

Fadhilah. (2024). Buku ajar keperawatan gerontik untuk DIII keperawatan. PT Nuansa Fajar Cemerlang.

Fitch, A. K., & Bays, H. E. (2022). Obesity definition, diagnosis, bias, standard operating procedures (SOPs), and telehealth: An Obesity Medicine Association clinical practice statement. Obesity Pillars, 1. https://doi.org/10.1016/j.obpill.2021.100004

Foula, W. H., et al. (2020). Effect of a weight loss program on serum adiponectin and insulin resistance among overweight and obese premenopausal females. Journal of the Egyptian Public Health Association, 95(1). https://doi.org/10.1186/s42506-020-00060-z

Friedenreich, C. M., Ryder-Burbidge, C., & McNeil, J. (2021). Physical activity, obesity and sedentary behavior in cancer etiology: Epidemiologic evidence and biologic mechanisms. Molecular Oncology, 790–800. https://doi.org/10.1002/1878-0261.12772

García-García, I., et al. (2023). Assessing adipokines as potential biomarkers of dementia, Alzheimer’s disease, and mild cognitive impairment: A systematic review and meta-analysis. Obesity Reviews. https://doi.org/10.1111/obr.13573

Gilbert, T., et al. (2018). Association between peripheral leptin and adiponectin levels and cognitive decline in patients with neurocognitive disorders ≥65 years. Journal of Alzheimer’s Disease, 66(3), 1255–1264. https://doi.org/10.3233/JAD-180533

Gorska-Ciebiada, M., & Ciebiada, M. (2024). Adiponectin and inflammatory marker levels in elderly patients with diabetes, mild cognitive impairment and depressive symptoms. International Journal of Molecular Sciences, 25(19). https://doi.org/10.3390/ijms251910804

Gozukara Bag, H. G., et al. (2023). Estimation of obesity levels through a predictive approach based on physical activity and nutritional habits. Diagnostics, 13(18). https://doi.org/10.3390/diagnostics13182949

Gupta, R. D., et al. (2023). Obesity and abdominal obesity in Indian population. Epidemiologia, 4(2), 163–172. https://doi.org/10.3390/epidemiologia4020017

Han, Y., et al. (2024). New advances of adiponectin in regulating obesity and related metabolic syndromes. Journal of Pharmaceutical Analysis. https://doi.org/10.1016/j.jpha.2023.12.003

Henney, A. E., et al. (2024). Obesity pharmacotherapy in older adults: A narrative review of evidence. International Journal of Obesity. https://doi.org/10.1038/s41366-024-01529-z

Janić, M., et al. (2025). Obesity: Recent advances and future perspectives. Biomedicines, 13(2), 368. https://doi.org/10.3390/biomedicines13020368

Jayanama, K., et al. (2022). Relationship of body mass index with frailty and all-cause mortality among middle-aged and older adults. BMC Medicine, 20(1). https://doi.org/10.1186/s12916-022-02596-7

Jeong, K. H., et al. (2024). Factors affecting cognitive function in older adults: A sex-specific analysis. Journal of Men’s Health, 20(8), 48–55. https://doi.org/10.22514/jomh.2024.128

Jian, M., et al. (2019). Adiponectin suppresses amyloid-β-induced inflammatory responses via AdipoR1-AMPK-NF-κB signaling. Journal of Neuroinflammation, 16(1). https://doi.org/10.1186/s12974-019-1492-6

Jin, X., et al. (2023). Pathophysiology of obesity and associated diseases. Acta Pharmaceutica Sinica B, 2403–2424. https://doi.org/10.1016/j.apsb.2023.01.012

Khaleghi, A. A., et al. (2025). Global prevalence of obesity in older adults: A meta-analysis. Public Health in Practice, 9, 100585. https://doi.org/10.1016/j.puhip.2025.100585

Khoramipour, K., et al. (2021). Adiponectin: Structure, physiological functions, role in diseases, and effects of nutrition. Nutrients, 13(4). https://doi.org/10.3390/nu13041180

Kim, S. E., et al. (2023). Resting-state electroencephalographic characteristics related to mild cognitive impairments. Frontiers in Psychiatry, 14. https://doi.org/10.3389/fpsyt.2023.1231861

Latino, F., & Tafuri, F. (2024). Physical activity and cognitive functioning. Medicina, 60(2). https://doi.org/10.3390/medicina60020216

Liu, F. J., et al. (2022). Decreased adiponectin levels as a risk factor for cognitive decline in spinal cord injury. Disease Markers, 2022. https://doi.org/10.1155/2022/5389162

Mabiama, G., et al. (2022). Undernutrition, overweight and obesity among community-dwelling elderly in Africa. Clinical Nutrition Open Science, 42–56. https://doi.org/10.1016/j.nutos.2022.08.004

Min, J. Y., Kim, B., & Min, K. B. (2023). Associations between cognitive function, depressive symptoms, and contact with adult children. Journal of Clinical Medicine, 12(16). https://doi.org/10.3390/jcm12165431

Moon, H. U., et al. (2019). Association of adiponectin and visceral fat with insulin resistance. Journal of Korean Medical Science, 34(1). https://doi.org/10.3346/jkms.2019.34.e7

Rambe, A. S., & Fitri, F. I. (2017). Correlation between MoCA-INA and MMSE in elderly. Open Access Macedonian Journal of Medical Sciences, 5(7), 915–919. https://doi.org/10.3889/oamjms.2017.202

Rizzo, M. R., Fasano, R., & Paolisso, G. (2020). Adiponectin and cognitive decline. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms21062010

Rubino, F., et al. (2025). Definition and diagnostic criteria of clinical obesity. The Lancet Diabetes & Endocrinology [Preprint]. https://doi.org/10.1016/S2213-8587(24)00316-4

Saraswati, S. K., et al. (2021). Literature review: Faktor risiko penyebab obesitas. Media Kesehatan Masyarakat Indonesia, 20(1), 70–74. https://doi.org/10.14710/mkmi.20.1.70-74

Senkus, K. E., et al. (2022). Relative fat mass assessment estimates adiposity changes among female older adults with obesity. Annals of Medicine, 54(1), 1160–1166. https://doi.org/10.1080/07853890.2022.2067352

Sindzingre, L., et al. (2024). The role of adiponectin in Alzheimer’s disease: A translational review. Journal of Nutrition, Health and Aging. https://doi.org/10.1016/j.jnha.2024.100166

Srinivas, N. S., et al. (2021). Cognitive function enhancement through physical exercises. Brain Sciences. https://doi.org/10.3390/brainsci11101289

Tasnim, N., et al. (2023). Effects of adiponectin and leptin correlating obesity with cognitive decline. Annals of Medicine & Surgery, 85(6), 2906–2915. https://doi.org/10.1097/MS9.0000000000000766

Tuwu, D., & Tarifu, L. (2023). Implementasi program posyandu lansia. Journal Publicuho, 6(1), 20–29. https://doi.org/10.35817/publicuho.v6i1.72

Utami, N., Effendy, E., & Amin, M. (2019). BDNF serum level and cognitive function in schizophrenia patients measured by MoCA-Ina. Open Access Macedonian Journal of Medical Sciences, 7(23), 4053–4058. https://doi.org/10.3889/oamjms.2019.705

World Health Organization. (2000). The Asia-Pacific perspective: Redefining obesity and its treatment. Health Communications Australia. https://iris.who.int/handle/10665/206936

World Health Organization. (2024). Ageing and health.

Zara, N. (2021). Gambaran fungsi kognitif berdasarkan MMSE pada pasien diabetes mellitus. Jurnal Kesehatan Almuslim, 7(2). https://doi.org/10.51179/jka.v7i2.679